SCHEMBL5769801

SCHEMBL5769801

COc1cccc(-c2sc(-c3n[nH]c4ccccc34)nc2C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 3/20 0.48
NR1I2 O75469 1/20 0.44
CYP1A2 P05177 1/20 0.44
VDR P11473 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2B6 P20813 1/20 0.44
AHR P35869 1/20 0.44
NR1I3 Q14994 1/20 0.44
TTK P33981 2/20 0.43
GAA P10253 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALPL P05186 1/20 0.43
IDO1 P14902 1/20 0.43
HPGD P15428 1/20 0.43
MAPK10 P53779 1/20 0.43
AURKA O14965 1/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5773591 0.84 JAK2 (0.47) ITKTTKGAAKDM4EALDH1A1
SCHEMBL5872883 0.84 ADORA2A (0.42) GAAMAPTSMN1; SMN2RAB9ANR1H2
SCHEMBL5873029 0.82 ITK (0.43) ITKTTKGAAKDM4EALDH1A1
SCHEMBL15622271 0.82 AURKA (0.60) ITKNR1I2CYP1A2VDRCYP2C9
SCHEMBL5772763 0.79 CYP19A1 (0.57) ITKNR1I2CYP1A2VDRCYP2C9
SCHEMBL5872971 0.78 KDM4E (0.44) ITKCYP1A2TTKGAAKDM4E
SCHEMBL5772793 0.77 JAK2 (0.43) ITKTTKGAAKDM4EALDH1A1
SCHEMBL327291 0.75 MEN1 (0.54) GAAKDM4EALDH1A1HPGDMAPT
SCHEMBL5774743 0.74 IDO1 (0.43) ITKCYP1A2TTKGAAKDM4E
SCHEMBL5771654 0.74 ALDH1A1 (0.65) ITKCYP1A2TTKGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664040-A1 GYRASE INHIBITORS PFIZER INC. (US) 2006-06-07 EP disclosed
US-6984652-B2 Gyrase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2006-01-10 US disclosed
US-20050250823-A1 Gyrase inhibitors YAGER KRAIG 2005-11-10 US disclosed
WO-2005026162-A1 GYRASE INHIBITORS PFIZER INC. (US) 2005-03-24 WO disclosed
US-20050054697-A1 Gyrase inhibitors PFIZER INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054697-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ITK 1969/4885NR1I2 640/4885CYP1A2 1113/4885
US-20050250823-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ITK 1969/4885NR1I2 640/4885CYP1A2 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.